Joaquín Diaz‐Mediavilla

Definition of relapse risk and role of nonanthracycline drugs for consolidation in patients with acute promyelocytic leukemia: a joint study of the PETHEMA and GIMEMA cooperative groups.

Miguel Á. Sanz, Giuseppe Avvisati, Consuelo Rayón et al. · PubMed · 2000 · 632 citations

Medicine, Oncology, Pharmacology +17

Superiority of bortezomib, thalidomide, and dexamethasone (VTD) as induction pretransplantation therapy in multiple myeloma: a randomized phase 3 PETHEMA/GEM study

Laura Rosiñol, Albert Oriol, Ana Isabel Teruel et al. · Blood · 2012 · 485 citations · Full text

Medicine, Hematology, Pharmacology +14

A modified AIDA protocol with anthracycline-based consolidation results in high antileukemic efficacy and reduced toxicity in newly diagnosed PML/RARalpha-positive acute promyelocytic leukemia. PETHEMA group.

Miguel Á. Sanz, Consuelo Rayón, Jordi Esteve et al. · PubMed · 1999 · 410 citations

Medicine, Oncology, Pharmacology +15

Bortezomib plus melphalan and prednisone in elderly untreated patients with multiple myeloma: results of a multicenter phase 1/2 study

María‐Victoria Mateos, JoséM. Hernández, M.B. Gómez Hernández et al. · Blood · 2006 · 389 citations · Full text

Medicine, Hematology, Oncology +15

Differentiation syndrome in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and anthracycline chemotherapy: characteristics, outcome, and prognostic factors

Pau Montesinos, Juan Bergua, Edo Vellenga et al. · Blood · 2008 · 364 citations · Full text

Medicine, Hematology, Oncology +17